You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
格隆匯港股聚焦(10.26)︱螞蟻集團H股IPO定價80港元,預計11月5日掛牌
格隆匯 10-26 22:04

【分拆上市】

融創中國(01918.HK):融創服務已通過港交所聆訊

【新股上市】

螞蟻集團(06688.HK)H股IPO定價80港元 預計11月5日掛牌

【財務數據】

東方證券(03958.HK)業績快報:前三季度淨利升75.20%至30.51億元

上海電氣(02727.HK)前三季度扣非淨利升21.62%至18.36億元

中國神華(01088.HK)前三季度純利降10.1%至325.78億元

招金礦業(01818.HK)前三季度淨利升181.11%至8.91億元

山水水泥(00691.HK)前三季度純利跌6.73%至23.32億元

重慶鋼鐵股份(01053.HK):前三季淨利同比降48.56%至3.7億元

金山軟件(03888.HK)附屬金山辦公前三季度純利升191.22%至5.95億元

浙江世寶(01057.HK)前三季度淨利升211.17%至3867.61萬元

業績預告】

阿里健康(00241.HK)中期業績扭虧 預盈不少於2億元

【運營數據】

東風集團(00489.HK)9月汽車銷量同比升10.27%至29.5萬輛

增減持】

雅居樂集團(03383.HK)增持32萬股雅生活H股 持股比例升至54.02%

維達國際(03331.HK)主席斥1092.04萬港元增持50萬股

【併購出售】

恆騰網絡(00136.HK)擬斥72億港元全資收購儒意影業

北京北辰實業股份(00588.HK)19.28億元競得杭州富陽地塊

保德國際發展(00372.HK)擬認購不超3120萬港元藥明巨諾國際發售股份

一拖股份(601038.SH)附屬擬4804.75萬元轉讓對國機重工(洛陽)公司全部債權予國機重工公司

【重大事項】

四環醫藥(00460.HK):獨家代理的韓國肉毒毒素產品“樂提葆”獲批於中國市場推出

交銀國際(03329.HK)附屬斥6億元戰略認購螞蟻集團A股

長和(00001.HK)旗下赫斯基擬與Cenovus合併組建能源公司

海普瑞(09989.HK):依諾肝素鈉注射液全部規格率先通過一致性評價

【基金理財】

南方航空(01055.HK)認購105.25億元光大銀行對公大額存單產品

【分紅付息】

融創中國(01918.HK)擬實物分派1.5億股融創服務股份作特別息

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account